Future Aspects in Contraception
Proceedings of an International Symposium held in Heidelberg, 5-8 September 1984 Part 2 Female Contraception
PAYBACK Punkte
20 °P sammeln!
of Part 2.- 1 Natural family planning.- 2 Barrier methods of contraception.- 3 Chemistry, contraceptive activity and toxicology of aryl guanidinobenzoates: inhibitors of sperm acrosin.- 4 Measurement of LH in saliva: a new approach to ovulation detection.- 5 Steroid-induced side-effects of oral contraceptives.- 6 Efficacy and physiology of a triphasic oral contraceptive.- 7 Advantages and disadvantages of low-dose hormonal contraceptive agents.- 8 Emerging routes of delivery for fertility-control agents.- 9 Current status of NORPLANT subdermal implants for contraception.- 10 New aspects in pos...
of Part 2.- 1 Natural family planning.- 2 Barrier methods of contraception.- 3 Chemistry, contraceptive activity and toxicology of aryl guanidinobenzoates: inhibitors of sperm acrosin.- 4 Measurement of LH in saliva: a new approach to ovulation detection.- 5 Steroid-induced side-effects of oral contraceptives.- 6 Efficacy and physiology of a triphasic oral contraceptive.- 7 Advantages and disadvantages of low-dose hormonal contraceptive agents.- 8 Emerging routes of delivery for fertility-control agents.- 9 Current status of NORPLANT subdermal implants for contraception.- 10 New aspects in post-coital contraception.- 11 Biological evaluation of some medicinal plant extracts for contraceptive efficacy in females.- 12 Pharmacokinetic and antigenicity studies with LHRH analogues.- 13 LHRH nasal spray in contraception.- 14 Acute and intermittent LHRH agonist dosing as post-coital and anti-ovulatory contraceptive approaches.- 15 LHRH antagonists and contraception.- 16 Mechanism of action of gonadotrophin releasing hormone in the pituitary and gonads.- 17 Morphological changes on the surface of IUDs: are they of clinical significance?.- 18 The use of non-culture tests for the detection of VD prior to IUD insertion: a view towards the future.- 19 Experience with GYNE-T Cu-380-A intrauterine contraceptive device (1981¿1984).- 20 Ten years¿ experience with continuous use of the butterfly IUD.- 21 The antiprogesterone activity of RU 486, a contragestive agent in the human.- 22 Effects of the anti progesterone RU 486 in early pregnancy and during the menstrual cycle.- 23 Prostaglandins in contraception.- 24 Ovarian hormones and cybernins.- 25 Biochemical aspects of a contraception model based on immunological properties of proteohormones.- 26 Variability in antisperm and antiembryonic humoral immune responses.- 27 Research for the development of an hCG antifertility vaccine.- 28 Present and future aspects of immunological methods in contraception.- 29 Preclinical and clinical aspects of safety in contraception.- 30 The politics of contraception.- 31 Contraceptive futurology: or 1984 in 1984.
Andere Kunden interessierten sich für
